Joe Pojman, executive director of the Texas Alliance for Life, defended the bill, saying it was necessary because the Food and Drug Administration could permanently lift the in-person dispensing requirements.
The FDA requires mifepristone, one of the two pills, to be distributed in clinics or doctors’ offices rather than prescribed and picked up at pharmacies or ivered by . In May, the Biden administration announced that it would review the requirements.
Amid the coronavirus pandemic, a group of doctors and advocates challenged the rule so patients could order it by . The agency temporarily eliminated the requirements on mifepristone first in July 2020, in response to a court order that was later reversed by the Supreme Court, and again in April.
“We’re strongly in support of the bill” and “we’re very happy it has passed, and we expect the governor to sign it into law very quickly,” Pojman said.